ABSTRACT
Background The six-minute walk test (6MWT), a simple, reliable and valid test that uses the distance walked in six minutes (six-minute walk distance, 6MWD) to quantify functional capacity, is widely used in chronic cardiopulmonary and non-cardiopulmonary disorders. However, absence of reference standards for Nigerian school-age children limits its use in this age group.
Objectives To develop normative values and equations for the 6MWT of school-aged Nigerian children.
Methods In a cross-sectional study, healthy children aged 6-11 years in Lagos, Nigeria, completed 6MWT on 20-meter straight outdoor courses in their schools following standardized guidelines. Potential predictors: demographic (age, sex), anthropometric (height, weight, chest circumference, leg length) and physiologic data [pre-walk, immediate post-walk and 5th minute-post-walk heart rate (HR), oxygen saturation (SpO2), systolic pressure (SBP), diastolic blood pressure (DBP) and rating of perceived exertion (RPE)] and difference between pre-walk and post-walk HR (ΔHR), SpO2 ((ΔSpO2), SBP (ΔSBP), DBP (ΔDBP) and RPE (ΔRPE). Primary outcome: six-minute walk distance (6MWD) in metres.
Results Overall, 627 pupils (52.1% girls) walked 504.6 ± 66.6 m (95% CI: 499.4, 509.8), ranging from 326.6 m to 673.0 m; 16 m longer in boys (p=0.002). Stepwise linear regression yielded: 6MWD (m) = 347.9 + 14 (Age) + 1.6 (ΔHR) + 17.6 (Sex) + 1.2 (ΔSBP); R2 =0.25. Previously published reference equations over-estimated Nigerian children’s 6MWD.
Conclusion The reference values and prediction equations, after validation in other Nigerian populations, may be useful for functional evaluation of Nigerian children aged 6-11 years with chronic childhood disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Health Research Ethics Committee of the Lagos State University Teaching Hospital (LASUTH), Ikeja, Lagos, Nigeria, gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript and supplementary file, but further details are available on request from the lead author
